Posted on Leave a comment

Yeshiva University to Open First Specialty Clinic in the U.S. to Focus on Addressing Non-Verbal Learning Disorder

“There continues to be a limited availability of mental health and educational professionals who are knowledgeable about NVLD, and able to provide individuals with NVLD and their families with much needed psychological and educational support,” adds Dr. Leslie Halpern, Dean of Yeshiva University Ferkauf Graduate School of Psychology. “We are pleased to help fill this […]

Posted on Leave a comment

Therapeutic Drug Monitoring Market worth $2.9 billion by 2027 – Exclusive Report by MarketsandMarkets™

Germany in European Therapeutic drug monitoring market to witness the highest shares during the forecast period. Browse 178 market data Tables and 50 Figures spread through 221 Pages and in-depth TOC on “Therapeutic Drug Monitoring Market by Product (Consumables, Equipment-Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers), Technology, Class of drugs, End user and […]

Posted on Leave a comment

eHealth Market worth $193.8 billion by 2025 – Exclusive Report by MarketsandMarkets™

The players in the eHealth market include Allscripts (US), athenahealth (US), Epic Systems (US), IBM (US), GE Healthcare (US), Cerner (US), Optum (US), Philips Healthcare (Netherlands) Browse 181 market data Tables and 38 Figures spread through 270 Pages and in-depth TOC on “eHealth Market by Solutions (EMR, PACS & VNA, RIS, LIS, CVIS, Telehealth, eRx, […]

Posted on Leave a comment

Medical Tourism Market Report 2023-2028: Size, Growth Statistics, Trends Analysis and Forecast

Medical Tourism Market Due to the accessibility to numerous medical treatments, including the availability of medical tourism packages and online medical services, making medical tourism more convenient and affordable, this is impacting the market favorably. What is the Market Size of Medical Tourism Market? IMARC Group’s latest research report, titled “Medical Tourism Market: Global Industry […]

Posted on Leave a comment

Acurx Pharmaceuticals CEO Is Confident His Ibezapolstat Can Earn Front-Line Designation To Treat C. difficile…Here’s Why ($ACXP)

Acurx Pharmaceuticals’ (NASDAQ: ACXP) mission in bringing to market an effective and durable treatment for C. difficile was provided a significant step forward. This time, it came as a result of yet another Phase 3 topline miss, with the late-stage clinical trial competitor Finch Therapeutics (NASDAQ: FNCH) reporting its terminating development stage programs for its […]

Posted on Leave a comment

80+ Leading Psoriasis Pipeline Companies are working to improve the Treatment Landscape

DelveInsight’s, “Psoriasis Pipeline Insight, 2023,” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Psoriasis pipeline landscape. It covers the Psoriasis pipeline drug profiles, including Psoriasis clinical trials and nonclinical stage products. It also covers the Psoriasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further […]

Posted on Leave a comment

SCALE Healthcare Receives Award for Best Online Health Education Platform

CEO Roy Bejarano’s Goal Is Building the Best Healthcare Management Community In the Industry New York, New York – February 7, 2023 – SCALE Healthcare, the premiere  healthcare solutions organization offering healthcare management teams the expertise, knowledge and tools to solve multidisciplinary challenges, has been recognized by Stellar Business with the award for Best Online […]

Posted on Leave a comment

Top Rated Doctor Announces New Vein Practice in Wilmington, NC

We’re excited to be back and have a prominent presence in the Mayfaire area! This boutique-style setting focuses more on patient experience and quality of treatment rather than quantity of patients or a clinical environment with long-wait times, various providers, etc. We believe this is why we are fundamentally different. This new location allows quicker […]

Posted on Leave a comment

CAR T-cells/CAR NK Cell Glioblastoma Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Glioblastoma pipeline constitutes key companies continuously working towards developing Glioblastoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Glioblastoma Overview Grade IV glioblastomas are aggressive, malignant brain tumors that develop from the brain’s glial cells. Tumors with the potential to spread and infect adjacent cells are […]

Posted on Leave a comment

Gastroesophageal Reflux Disease Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Gastroesophageal Reflux Disease pipeline constitutes 9+ key companies continuously working towards developing 12+ Gastroesophageal Reflux Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Gastroesophageal Reflux Disease Overview The chronic gastrointestinal disorder gastroesophageal reflux disease (GERD) is defined by the regurgitation of stomach contents into the […]